Hensley Mark Earl bought HRTX
May 6, 2026 · Form 4 insider transaction
Hensley Mark Earl bought 125,000 shares of Heron Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
125,000
Price
N/A
Total value
N/A
InsiderHensley Mark Earl
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 6, 2026
Filing dateMay 7, 2026
Shares owned after136,770
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock.